Irbesartan is a non-peptide angiotensin II-competitive antagonist indicated for hypertension and diabetic nephropathy in hypertensive patients with type 2 diabetes, elevated serum creatinine, and proteinuria [74]. Here, AGT is linked to hypertensive disorder.